Konstanze Kleinschnitz

Statistics

Publications

Citations

326

H-Index

Active since

2013

Affiliations

Heinrich Heine University Düsseldorf(Current)

Justus-Liebig-Universität Gießen

Hertie Foundation

University of Göttingen

Essen University Hospital

Konstanze Kleinschnitz is an author at Heinrich Heine University Düsseldorf specializing in immunotherapy, relapsing-remitting multiple sclerosis treatment, and inclusion body myositis.

Publications per year

2013–2024

Publications

Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19

Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer et al. · Neurology Neuroimmunology & Neuroinflammation · 2021 · 111 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +15

Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres

Steffen Pfeuffer, Leoni Rolfes, Jana Hackert et al. · Multiple Sclerosis Journal · 2021 · 78 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis

Ingrid E. Muth, Jana Zschüntzsch, Konstanze Kleinschnitz et al. · Experimental Neurology · 2015 · 31 citations

Medicine, Immunology, Pathology +16

Immunological consequences of cladribine treatment in multiple sclerosis: A real-world study

Leoni Rolfes, Steffen Pfeuffer, Niklas Huntemann et al. · Multiple Sclerosis and Related Disorders · 2022 · 27 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM

Karsten Schmidt, Konstanze Kleinschnitz, Goran Rakočević et al. · BMC Neurology · 2016 · 22 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

1–5 of 9